Most Nifty Indexes' largest components have a very large weighting on their performance, and Nifty Pharma is no exception. Sun Pharmaceuticals represents roughly a quarter of the index, so today we're going to look at it's role as a potential leading indicator for the rest of the sector.
Below is a daily line chart of the Nifty Pharma Index overlayed with Sun Pharmaceuticals. What we see from this relationship is that Sun Pharma generally leads the index, so when it's showing relative strength a move higher is likely, and when it's showing relative weakness then a move lower is likely. The two rarely separate from each other for long.
Interest rates are on the move, with the Ten-Year Treasury Yield breaking 3% once again after working off its failed breakout attempt from May. One relationship that's highly correlated with the Ten-Year Yield is Regional Banks vs REITS. We've written about this relationship in 2016 and 2017, but it's at an important inflection point so today's chart is going to revisit it.
It's the end of the month, which means we've got new monthly charts. Last month we discussed the strength in large-cap Financial Services, Consumer Goods, IT, and in certain areas of Pharma, while the weakest areas were mid and small-cap Infrastructure, Metals, Commodities, Realty, Media, and Autos. This post is going to discuss any significant changes from last month, but members can find the rest of the updated charts in the Chartbook.
The strength in large-caps continues, as shown by the Nifty 50 making a new all-time closing high. This month's candle opened at the lows and closed at the highs, signaling a continuation of its uptrend after 6 months of consolidation. If prices are above 11,165 we want to be long as our next price objective us up near 15,260.
Based on the great feedback we receive every day, we know a lot of Allstarcharts India readers have an interest in the mid-cap and small-cap segments of the market. Typically we cover those areas in the Monthly Conference Call, followed by a deep dive (or two) on anything that we didn't have time to discuss. Additionally, we publish shorter posts throughout the month highlighting opportunities as they emerge.
While a good start, we wanted to create something to provide more regular coverage of the space, so we've added nearly 100 mid and small-cap stocks to the Chartbook feature of our site. To narrow this universe down to a manageable size, these lists include those stocks that are available to short via futures and/or options, so that we can provide consistent analysis on both sides of the trade as we do in the other Chartbooks.
When I thought of the title for this post I was hoping to make a Nascar analogy, but quickly realized I don't know anything about Nascar or racing. With that aside, what's clear from our recent blog posts is that we remain bullish on US Equities but open-minded to the new data we're getting each day. As I was going through my sector chartbook this weekend I identified a few momentum divergences that have emerged, as well as some bullish data points that potentially offset them, so this post will quickly go through my findings and key takeaways.
This weekend all of the Chartbooks on the site were updated, so this is a quick post to highlight some of the significant developments since they were last updated.
The broad-based Financials ETF $XLF has gone basically sideways for the majority of the year, but under the surface there has been strength in individual names and sub-sectors like Broker-Dealers and Exchanges. We've spoken a lot about them in the past, so today I want to talk focus on several stocks showing relative strength that are setting up on the long side.
The Nasdaq Composite closed at another all-time high yesterday, but some are questioning this rally's sustainability due to the under-performance of the Semiconductor Index. Given we're open-minded about our bullish Technology thesis, we want to use this post to take explore the sector's recent performance and its possible implications.
This post is part two of the semiconductor discussion that began here, with us outlining the current trend in Semiconductors from the top-down. If you've not read that yet, I suggest you do as this post will focus on the specific stocks we want to be involved in to capitalize on the eventual continuation of this sector's uptrend.
This week I was in New York meeting with partners and old friends. On Tuesday I was down at the Bloomberg Headquarters chatting with Catherine Murray about what we're seeing from a technical perspective. We discuss Technology, Medical Equipment stocks and where we are within this secular bull market. Here's the video of the interview:
